217 related articles for article (PubMed ID: 34341073)
1. PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer.
Zhao Z; Szczepanski AP; Tsuboyama N; Abdala-Valencia H; Goo YA; Singer BD; Bartom ET; Yue F; Wang L
Cancer Res; 2021 Sep; 81(18):4696-4708. PubMed ID: 34341073
[TBL] [Abstract][Full Text] [Related]
2. ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.
Szczepanski AP; Zhao Z; Sosnowski T; Goo YA; Bartom ET; Wang L
Genome Med; 2020 Jul; 12(1):63. PubMed ID: 32669118
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer.
Tsuboyama N; Wang R; Szczepanski AP; Chen H; Zhao Z; Shi L; Wang L
Oncogene; 2022 Apr; 41(15):2152-2162. PubMed ID: 35194152
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis.
Bhol CS; Patil S; Sahu BB; Patra SK; Bhutia SK
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188561. PubMed ID: 33965511
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional epigenetic regulation of Fkbp1/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer.
Soto JA; Rodríguez-Antolín C; Vera O; Pernía O; Esteban-Rodríguez I; Dolores Diestro M; Benitez J; Sánchez-Cabo F; Alvarez R; De Castro J; Ibanez de Cáceres I
Clin Epigenetics; 2021 Aug; 13(1):167. PubMed ID: 34454589
[TBL] [Abstract][Full Text] [Related]
6. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
7. PAX9 in Cancer Development.
Chen X; Li Y; Paiboonrungruang C; Li Y; Peters H; Kist R; Xiong Z
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628401
[TBL] [Abstract][Full Text] [Related]
8. Kdm1a promotes SCLC progression by transcriptionally silencing the tumor suppressor Rest.
Jin Y; Ma D; Gramyk T; Guo C; Fang R; Ji H; Shi YG
Biochem Biophys Res Commun; 2019 Jul; 515(1):214-221. PubMed ID: 31146914
[TBL] [Abstract][Full Text] [Related]
9. PAX9 regulates squamous cell differentiation and carcinogenesis in the oro-oesophageal epithelium.
Xiong Z; Ren S; Chen H; Liu Y; Huang C; Zhang YL; Odera JO; Chen T; Kist R; Peters H; Garman K; Sun Z; Chen X
J Pathol; 2018 Feb; 244(2):164-175. PubMed ID: 29055049
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
11. PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Kanteti R; Nallasura V; Loganathan S; Tretiakova M; Kroll T; Krishnaswamy S; Faoro L; Cagle P; Husain AN; Vokes EE; Lang D; Salgia R
Lab Invest; 2009 Mar; 89(3):301-14. PubMed ID: 19139719
[TBL] [Abstract][Full Text] [Related]
12. The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.
Kalari S; Jung M; Kernstine KH; Takahashi T; Pfeifer GP
Oncogene; 2013 Jul; 32(30):3559-68. PubMed ID: 22907430
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of tamoxifen-inducible Pax9-CreER knock-in mice using CrispR/Cas9.
Feng J; Jing J; Sanchez-Lara PA; Bootwalla MS; Buckley J; Wu N; Yan Y; Chai Y
Genesis; 2016 Sep; 54(9):490-6. PubMed ID: 27381449
[TBL] [Abstract][Full Text] [Related]
14. Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c-myb.
Lee JC; Sharma M; Lee YH; Lee NH; Kim SY; Yun JS; Nam SY; Hwang PH; Jhee EC; Yi HK
Cell Biochem Funct; 2008 Dec; 26(8):892-9. PubMed ID: 18979497
[TBL] [Abstract][Full Text] [Related]
15. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression.
Luszczek W; Cheriyath V; Mekhail TM; Borden EC
Mol Cancer Ther; 2010 Aug; 9(8):2309-21. PubMed ID: 20682643
[TBL] [Abstract][Full Text] [Related]
16. ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.
Shukla V; Rao M; Zhang H; Beers J; Wangsa D; Wangsa D; Buishand FO; Wang Y; Yu Z; Stevenson HS; Reardon ES; McLoughlin KC; Kaufman AS; Payabyab EC; Hong JA; Zhang M; Davis S; Edelman D; Chen G; Miettinen MM; Restifo NP; Ried T; Meltzer PA; Schrump DS
Cancer Res; 2017 Nov; 77(22):6267-6281. PubMed ID: 28935813
[TBL] [Abstract][Full Text] [Related]
17. Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9.
Tan K; Shaw AL; Madsen B; Jensen K; Taylor-Papadimitriou J; Freemont PS
J Biol Chem; 2003 Jun; 278(23):20507-13. PubMed ID: 12657635
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression.
Lenhart R; Kirov S; Desilva H; Cao J; Lei M; Johnston K; Peterson R; Schweizer L; Purandare A; Ross-Macdonald P; Fairchild C; Wong T; Wee S
Mol Cancer Ther; 2015 Oct; 14(10):2167-74. PubMed ID: 26253517
[TBL] [Abstract][Full Text] [Related]
19. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of Nkx2.1 and Pax9 for calcitonin gene transcription.
Suzuki M; Katagiri N; Ueda M; Tanaka S
Gen Comp Endocrinol; 2007; 152(2-3):259-66. PubMed ID: 17412341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]